More than career growth — Shaping Vertexians’ tomorrows
2 min read
Learn why the Vertex Pharmaceuticals approach to career growth is unique from Chief Human Resources Officer Stephanie Franklin.
The Vertex Foundation — A look back at 2022
4 min read
Looking back on 2022, the Vertex Foundation remains grateful and excited for the future. From supporting healthy families to social innovation and STEAM education, we’re proud of the impact Foundation partners continue to make in our communities around the world.
Taking a patient-first approach to clinical trials
1 min read
Mark Higgins, Senior Director of Clinical Development, highlights Vertex’s patient-first approach to clinical trials and discusses his experience discovering potential treatments for people with cystic fibrosis.
Catalysts for change
3 min read
ID&E Week is our annual opportunity to press pause and listen, learn and reflect. This year’s theme, “Catalysts for Change,” was also a call to action for Vertexians to ignite actionable change. Hear from Vice President Diana Cruz Solash on key takeaways from our sixth annual ID&E Week.
Vertex employees share their experiences with type 1 diabetes
6 min read
We are lucky to have some of our very own ‘Vertexians’ willing to share their stories about living with or caring for someone with T1D. We invite you to learn from them and help raise awareness for T1D this month.
The power of allyship
6 min read
We're celebrating our sixth annual ID&E Week at Vertex with the theme “Catalysts for Change.” Hear from Senior Vice President Ludovic Fenaux and our international Employee Resource Network (ERN) co-leads about the power of allyship and how we can all become catalysts for change.
See inside. See cystic fibrosis
1 min read
Cystic fibrosis is a rare, genetic, progressive disease, in which symptoms and organ damage can manifest very early in life. These may not, however, be outwardly visible in all children and while some children can appear well on the outside, what is happening inside their bodies can tell a different story.
Vertex celebrates its 2022 Working Parents of the Year honorees
5 min read
Vertex is proud to share that it has been named — once again — to Seramount’s 100 Best Companies list and the Best Companies for Dads list. Learn more about what sets us apart and meet our Working Parents of the Year honorees, Genzy Davis and Ravin Warnakulasuriya.
Jonathan Biller
Executive Vice President and Chief Legal Officer
Jonathan Biller
Executive Vice President and Chief Legal Officer
Jonathan has deep legal, industry and business experience and expertise that will support our continued growth. He joined Vertex in 2022 and serves on the Executive Committee and oversees all aspects of our global legal and compliance functions.
Her earned his bachelor’s degree in history from Brown University and his law degree from Yale Law School. Prior to Vertex, Jonathan served in several executive roles at Agios Pharmaceuticals, including Chief Legal Officer and most recently Chief Financial Officer and Head of Corporate Affairs. Prior to this, he served as Executive Vice President, General Counsel at Celgene, where he was responsible for its global legal function, and before that as Senior Vice President, Tax and Treasury. Prior to Celgene, he served in various leadership roles at Bunge Limited and Alcon, Inc. He began his legal career at Hopkins & Sutter, rising to the level of partner, and was also partner at Foley & Lardner after the firms merged.
Jonathan has deep legal, industry and business experience and expertise that will support our continued growth. He joined Vertex in 2022 and serves on the Executive Committee and oversees all aspects of our global legal and compliance functions.
Her earned his bachelor’s degree in history from Brown University and his law degree from Yale Law School. Prior to Vertex, Jonathan served in several executive roles at Agios Pharmaceuticals, including Chief Legal Officer and most recently Chief Financial Officer and Head of Corporate Affairs. Prior to this, he served as Executive Vice President, General Counsel at Celgene, where he was responsible for its global legal function, and before that as Senior Vice President, Tax and Treasury. Prior to Celgene, he served in various leadership roles at Bunge Limited and Alcon, Inc. He began his legal career at Hopkins & Sutter, rising to the level of partner, and was also partner at Foley & Lardner after the firms merged.
A new Partnership to ignite change for sickle cell disease
3 min read
The Sickle Cell Disease Partnership is a multistakeholder coalition, launched in June, which works to improve care and access for people living with sickle cell disease. Here, Chief Patient Officer Amit Sachdev discusses the partnership, its goals and the reasons it was founded.